DrugPatentWatch Database Preview

IMODIUM Drug Profile

« Back to Dashboard

Which patents cover Imodium, and when can generic versions of Imodium launch?

Imodium is a drug marketed by J And J Consumer Inc and Janssen Pharms and is included in eight NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in IMODIUM is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.

Summary for IMODIUM

US Patents:	0
Applicants:	2
NDAs:	8
Bulk Api Vendors:	68
Clinical Trials:	19
Patent Applications:	1,639
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	IMODIUM at DailyMed

Synonyms for IMODIUM

1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-, hydrochloride

1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-, monohydrochloride

1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-,hydrochloride

34552-83-5

4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride

4-(4-(p-Chlorophenyl)-4-hydroxy-1-piperidyl)-N,N-dimethyl-2,2-diphenylbutyramide HCl

4-(4-chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidin-1-ium chloride

4-(4-chlorophenyl)-4-hydroxy- N,N-dimethyl-alpha,alpha-diphenyl- 1-piperidine butanamide

4-(4-Chlorophenyl)-4-hydroxy-N,.alpha.-diphenyl-1-piperidinebutanamide monohydrochloride

4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-?,?-diphenyl-1-piperidinebutanamide hydrochloride

4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidine butanamide

4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenylpiperidine-1-butyramide monohydrochloride

4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidine butyramide HCl

4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidinebutyramide hydrochloride

4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidinebutyramide monohydrochloride

4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride

4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide hydrochloride

4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride

4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-n,n-dimethyl-2,2-diphenylbutanamide;hydrochloride

4-[4-(4-chlorophenyl)-4-oxidanyl-piperidin-1-yl]-N,N-dimethyl-2,2-diphenyl-butanamide hydrochloride

53179-11-6 (Parent)

552L835

77TI35393C

A822272

AB0013105

AB2000588

AC-8242

AC1L2G4W

AC1Q3BBG

AKOS015846351

AN-8179

Anti-diarrheal

ARONIS27197

AS-13181

B1392

BC205117

BLOX

BREK

C29H33ClN2O2.HCl

C29H34Cl2N2O2

CCG-39494

CHEBI:6533

CHEMBL1707

CPD000058466

CS-2522

D00729

Diamode

Diar-Aid

Dissenten

EBD2202345

EINECS 252-082-4

EU-0100708

Fortasec

FT-0627973

H536

HMS1568M10

HMS1922J18

HY-B0418A

I06-0646

Imodium (TN)

Imodium A-D

Imodium A-D EZ chews

Imosec

Imotil

K-7865

K-Pek II

Kao-Paverin

Kaopectate 1-D

KS-00000GHZ

KS-000048OI

L 4762

L0154

Lopemid

Lopemin

Loperamide (hydrochloride)

Loperamide HCl

Loperamide hydrochloride

Loperamide hydrochloride (JAN/USP)

Loperamide hydrochloride [USAN:JAN]

Loperamide hydrochloride [USAN:USP:JAN]

Loperamide Hydrochloride Capsules

Loperamide hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard

Loperamide hydrochloride, European Pharmacopoeia (EP) Reference Standard

Loperamide hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur and BP

Loperamide hydrochloride, United States Pharmacopeia (USP) Reference Standard

Loperamide hydrochloride, VETRANAL(TM), analytical standard

Loperyl

Loseramin

LP00708

LS-114353

Maalox Antidiarrheal

MCULE-8938403173

MFCD00058581

MLS000069779

MLS001148627

MLS002222200

MolPort-003-666-775

NC00572

NCGC00094059-01

NCGC00094059-02

NCGC00094059-03

NCGC00094059-04

NCGC00094059-05

NCGC00180886-01

NCGC00180886-02

NCGC00261393-01

NSC-696356

NSC-759568

NSC696356

NSC759568

Opera_ID_1508

PGYPOBZJRVSMDS-UHFFFAOYSA-N

Pharmakon1600-02300241

PJ185

Prestwick_302

R 18,553

R 18553

REGID_for_CID_71420

s2480

SAM002564218

SCHEMBL15048

SMR000058466

SPECTRUM2300241

SR-01000075507

SR-01000075507-1

Suprasec

Tebloc

TL8002575

Tox21_500708

UNII-77TI35393C

Up and up anti diarrheal

W-106729

US Patents and Regulatory Information for IMODIUM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
J And J Consumer Inc	IMODIUM	loperamide hydrochloride	CAPSULE;ORAL	017690-001	Approved Prior to Jan 1, 1982		DISCN	No	No
J And J Consumer Inc	IMODIUM A-D EZ CHEWS	loperamide hydrochloride	TABLET, CHEWABLE;ORAL	020448-001	Jul 24, 1997		DISCN	Yes	No			Y
J And J Consumer Inc	IMODIUM A-D	loperamide hydrochloride	SOLUTION;ORAL	019487-001	Mar 1, 1988		OTC	Yes	Yes
J And J Consumer Inc	IMODIUM MULTI-SYMPTOM RELIEF	loperamide hydrochloride; simethicone	TABLET, CHEWABLE;ORAL	020606-001	Jun 26, 1996		DISCN	Yes	No

Expired US Patents for IMODIUM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
J And J Consumer Inc	IMODIUM	loperamide hydrochloride	CAPSULE;ORAL	017694-001	Approved Prior to Jan 1, 1982
Janssen Pharms	IMODIUM	loperamide hydrochloride	SOLUTION;ORAL	019037-001	Jul 31, 1984

Paragraph IV (Patent) Challenges for IMODIUM

Drugname	Dosage	Strength	RLD	Submissiondate
	Tablets	2 mg/125 mg		2004-12-29